UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

OC.04.3 EXPRESSION OF TBET AND RORGAMMA-T IN REGULATORY T CELLS INFLUENCE THE INCIDENCE AND SIZE OF TUMOR MASSES IN A CAC MODEL

Digestive and liver disease, 2016-02, Vol.48, p.e84-e84

2016

Volltextzugriff (PDF)

IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer

Cell cycle (Georgetown, Tex.), 2005-02, Vol.4 (2), p.220-223

2005

Volltextzugriff (PDF)

OC.01.2: Rorgamma-T-Expressing Regulatory T Cells Sustain Colorectal Cancer Growth Through a Foxo3-Dependent Suppression of Dendritic Cell-Derived IL-6 Production

Digestive and liver disease, 2017-03, Vol.49, p.e77-e77

2017

Volltextzugriff (PDF)

PC.01.3 COLITIS-ASSOCIATED COLORECTAL CANCER INDUCES PHENOTYPE INSTABILITY AND EFFECTOR FUNCTIONS IN TUMOR-INFILTRATING REGULATORY T CELLS

Digestive and liver disease, 2014-03, Vol.46, p.S2-S2

2014

Volltextzugriff (PDF)

OC.04.1 SMAD7 KNOCKDOWN IN COLON CANCER CELLS ACTIVATES PROTEIN KINASE RNA-ASSOCIATED EIF2-ALPHA PATHWAY THEREBY LEADING TO CELL DEATH

Digestive and liver disease, 2016-02, Vol.48, p.e83-e83

2016

Volltextzugriff (PDF)

P.13.10 SMAD7-MEDIATED SUPPRESSION OF IL-17A IN CD4+ T CELLS PREVENTS EARLY BUT NOT LATE STAGE COLORECTAL CANCER DEVELOPMENT

Digestive and liver disease, 2013-03, Vol.45, p.S184-S185

2013

Volltextzugriff (PDF)

OC.05.2 TH17-RELATED CYTOKINES AND EXCESSIVE ACTIVATION OF STAT3 SUSTAIN COLORECTAL CANCER CELL GROWTH

Digestive and liver disease, 2014-03, Vol.46, p.S13-S13

2014

Volltextzugriff (PDF)

PC.01.2 SMAD7 SUSTAINS COLON CANCER CELL GROWTH BY MODULATING PP1 AND EIF2-ALPHA TO REGULATE CDC25A

Digestive and liver disease, 2014-03, Vol.46, p.S1-S2

2014

Volltextzugriff (PDF)

T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY

Digestive and liver disease, 2024-04, Vol.56, p.S240-S240

2024

Volltextzugriff (PDF)

P.13.18 THE ENDOSCOPIC PERFORMANCE OF GASTROENTEROLOGY TRAINEES IN A TERTIARY GASTROINTESTINAL UNIT

Digestive and liver disease, 2014-03, Vol.46, p.S106-S107

2014

Volltextzugriff (PDF)

T.02.10 IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY

Digestive and liver disease, 2023-03, Vol.55, p.S144-S144

2023

Volltextzugriff (PDF)

T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

Digestive and liver disease, 2023-03, Vol.55, p.S159-S159

2023

Volltextzugriff (PDF)

OC.07.1: CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE P35 CYTOKINES SUBUNITS IN LPMC AND HIGH IL-23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

Digestive and liver disease, 2024-04, Vol.56, p.S161-S161

2024

Volltextzugriff (PDF)

OC.15.4 GENOTYPE-PHENOTYPE CORRELATION IN SARDINIAN PATIENTS WITH WILSON’S DISEASE

Digestive and liver disease, 2022-05, Vol.54, p.S107

2022

Volltextzugriff (PDF)

T.02.3 SELECTIVE OVER-EXPRESSION OF SMAD7 IN INTESTINAL EPITHELIAL CELLS RESULTS IN BARRIER DYSFUNCTION AND ILEITIS

Digestive and liver disease, 2023-03, Vol.55, p.S141-S141

2023

Volltextzugriff (PDF)

T.10.5 ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN ULCERATIVE COLITIS PATIENTS

Digestive and liver disease, 2023-03, Vol.55, p.S180-S180

2023

Volltextzugriff (PDF)

OC.03.9: IBD-DISK: ITALIAN TRANSLATION AND VALIDATION IN A POPULATION-BASED COHORT

Digestive and liver disease, 2024-04, Vol.56, p.S138-S138

2024

Volltextzugriff (PDF)

OC.03.1: ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN INFLAMMATORY BOWEL DISEASE

Digestive and liver disease, 2024-04, Vol.56, p.S133-S134

2024

Volltextzugriff (PDF)

BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY)

Digestive and liver disease, 2024-04, Vol.56, p.S120-S121

2024

Volltextzugriff (PDF)

OC.10.5 SAFETY OF ORAL MESALAMINE (5-ASA) IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT ULCERATIVE COLITIS PATIENTS

Digestive and liver disease, 2022-05, Vol.54, p.S94

2022

Volltextzugriff (PDF)

T.08.2 ROLE OF PNPLA3, TM6SF2 AND GCKR POLYMORPHISMS IN HEPATIC STEATOSIS IN WILSON’S DISEASE

Digestive and liver disease, 2022-05, Vol.54, p.S147

2022

Volltextzugriff (PDF)

OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES

Digestive and liver disease, 2011, Vol.43, p.S130-S130

2011

Volltextzugriff (PDF)

OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER

Digestive and liver disease, 2011, Vol.43, p.S130-S131

2011

Volltextzugriff (PDF)

P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS

Digestive and liver disease, 2010, Vol.42, p.S139-S139

2010

Volltextzugriff (PDF)

OC.07.5: BOWEL URGENCY IN PATIENTS WITH ULCERATIVE COLITIS: PREVALENCE AND ASSOCIATION WITH CLINICAL, ENDOSCOPIC DATA AND DISABILITY

Digestive and liver disease, 2024-04, Vol.56, p.S164-S165

2024

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(60)
Tagungsberichte
(2)

Sprache

Englisch
(62)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

OC.04.3 EXPRESSION OF TBET AND RORGAMMA-T IN REGULATORY T CELLS INFLUENCE THE INCIDENCE AND SIZE OF TUMOR MASSES IN A CAC MODEL

IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer

OC.01.2: Rorgamma-T-Expressing Regulatory T Cells Sustain Colorectal Cancer Growth Through a Foxo3-Dependent Suppression of Dendritic Cell-Derived IL-6 Production

PC.01.3 COLITIS-ASSOCIATED COLORECTAL CANCER INDUCES PHENOTYPE INSTABILITY AND EFFECTOR FUNCTIONS IN TUMOR-INFILTRATING REGULATORY T CELLS

OC.04.1 SMAD7 KNOCKDOWN IN COLON CANCER CELLS ACTIVATES PROTEIN KINASE RNA-ASSOCIATED EIF2-ALPHA PATHWAY THEREBY LEADING TO CELL DEATH

P.13.10 SMAD7-MEDIATED SUPPRESSION OF IL-17A IN CD4+ T CELLS PREVENTS EARLY BUT NOT LATE STAGE COLORECTAL CANCER DEVELOPMENT

OC.05.2 TH17-RELATED CYTOKINES AND EXCESSIVE ACTIVATION OF STAT3 SUSTAIN COLORECTAL CANCER CELL GROWTH

PC.01.2 SMAD7 SUSTAINS COLON CANCER CELL GROWTH BY MODULATING PP1 AND EIF2-ALPHA TO REGULATE CDC25A

T.04.7: ADHERENCE TO MEDITERRANEAN DIET AND DIET QUALITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER, OBSERVATIONAL CASE-CONTROL STUDY

P.13.18 THE ENDOSCOPIC PERFORMANCE OF GASTROENTEROLOGY TRAINEES IN A TERTIARY GASTROINTESTINAL UNIT

T.02.10 IRON-DEFICIENCY REFRACTORY ANEMIA (IDRA) IN SARDINIAN INFLAMMATORY BOWEL DISEASE PATIENTS: A LONGITUDINAL OBSERVATIONAL STUDY

T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

OC.07.1: CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE P35 CYTOKINES SUBUNITS IN LPMC AND HIGH IL-23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

OC.15.4 GENOTYPE-PHENOTYPE CORRELATION IN SARDINIAN PATIENTS WITH WILSON’S DISEASE

T.02.3 SELECTIVE OVER-EXPRESSION OF SMAD7 IN INTESTINAL EPITHELIAL CELLS RESULTS IN BARRIER DYSFUNCTION AND ILEITIS

T.10.5 ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN ULCERATIVE COLITIS PATIENTS

OC.03.9: IBD-DISK: ITALIAN TRANSLATION AND VALIDATION IN A POPULATION-BASED COHORT

OC.03.1: ALTERED EXPRESSION AND ENZYMATIC ACTIVITY OF XANTHINE OXIDASE IN INFLAMMATORY BOWEL DISEASE

BOC.04.1: ANALYSIS OF IMMUNOLOGICALVARIABLES IN EX VIVO TOFACITINIB-TREATED HUMAN BIOPSIES FROM ACTIVE ULCERATIVE COLITIS PATIENTS TO PREDICT CLINICAL RESPONSE (THE AVATAR STUDY)

OC.10.5 SAFETY OF ORAL MESALAMINE (5-ASA) IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT ULCERATIVE COLITIS PATIENTS

T.08.2 ROLE OF PNPLA3, TM6SF2 AND GCKR POLYMORPHISMS IN HEPATIC STEATOSIS IN WILSON’S DISEASE

OC.06.1: INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES

OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER

P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS

OC.07.5: BOWEL URGENCY IN PATIENTS WITH ULCERATIVE COLITIS: PREVALENCE AND ASSOCIATION WITH CLINICAL, ENDOSCOPIC DATA AND DISABILITY

Suchergebnisse filtern